Marshall Stanton - Mar 1, 2024 Form 4/A Insider Report for ARTIVION, INC. (AORT)

Role
SVP, Clinical & MD Affair
Signature
/s/ Marshall Stanton
Stock symbol
AORT
Transactions as of
Mar 1, 2024
Transactions value $
-$28,195
Form type
4/A
Date filed
3/14/2024, 08:06 PM
Date Of Original Report
Mar 7, 2024
Previous filing
Feb 29, 2024
Next filing
Mar 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Award $0 +5.72K +7.04% $0.00 87K Mar 1, 2024 Direct F1, F2
transaction AORT Common Stock Sale -$28.2K -1.51K -1.73% $18.72 85.5K Mar 1, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents LTIP performance stock units of which one hundred percent (100%) were issued on March 1, 2024.
F2 As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
F3 These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.